Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Prospective Analysis of Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies

Authors not listed

Abramson Cancer Center at Penn Medicine · 2018

Abstract

The purpose of this research study is to determine if frailty assessments can be used to predict how well patients aged 60 years and older will do after chemotherapy, CAR T-cell therapy, or allogeneic stem cell transplant.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-16 MST

Cite this

APA
Anonymous. (2018). Prospective Analysis of Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies. <em>Abramson Cancer Center at Penn Medicine</em>. https://clinicaltrials.gov/study/NCT03680677
Vancouver
Anonymous. Prospective Analysis of Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies. Abramson Cancer Center at Penn Medicine. 2018.
BibTeX
@misc{anon2018Prospe, title = {Prospective Analysis of Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies}, author = {Anonymous}, journal = {Abramson Cancer Center at Penn Medicine}, year = {2018}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings